Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13325
Country/Region: Uganda
Year: 2016
Main Partner: Reach Out Mbuya
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 2
GEND_GBV Age/Sex: <10 Male 2017 1
GEND_GBV Age/Sex: 10-14 Female 2017 6
GEND_GBV Age/Sex: 10-14 Male 2017 1
GEND_GBV Age/Sex: 15-19 Female 2017 8
GEND_GBV Age/Sex: 20-24 Female 2017 14
GEND_GBV Age/Sex: 20-24 Male 2017 2
GEND_GBV Age/Sex: 25-49 Female 2017 4
GEND_GBV Age/Sex: 25-49 Male 2017 2
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 4
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 9
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 31
GEND_GBV Number of people receiving post-GBV care 2017 40
GEND_GBV Sum of Age/Sex Disaggregates 2017 10
HTS_TST Age/sex: <1 2017 286
HTS_TST Age/sex: 1-9 2017 945
HTS_TST Age/sex: 10-14 Female 2017 815
HTS_TST Age/sex: 10-14 Male 2017 816
HTS_TST Age/sex: 15-19 Female 2017 1,138
HTS_TST Age/sex: 15-19 Male 2017 1,204
HTS_TST Age/sex: 20-24 Female 2017 1,708
HTS_TST Age/sex: 20-24 Male 2017 1,808
HTS_TST Age/sex: 25-49 Female 2017 2,619
HTS_TST Age/sex: 25-49 Male 2017 2,772
HTS_TST Age/sex: 50+ Female 2017 227
HTS_TST Age/sex: 50+ Male 2017 242
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,431
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,431
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 5,692
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 6,026
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 14,580
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,650
HTS_TST Service Delivery Point (Facility): Inpatient 2017 365
HTS_TST Service Delivery Point (Facility): Other PITC 2017 995
HTS_TST Service Delivery Point (Facility): Outpatient 2017 7,798
HTS_TST Service Delivery Point (Facility): Pediatric 2017 2,809
HTS_TST Service Delivery Point (Facility): PMTCT 2017 711
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 252
HTS_TST Sum of Age/Sex disaggregates 2017 13,349
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,862
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 11,718
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 14,580
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 39
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 40
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 68
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 51
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 102
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 76
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 156
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 117
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 13
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 10
HTS_TST_POS Test Result by Age: Positive: <1 2017 16
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 46
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 70
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 71
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 339
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 254
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 9
KP_PREV By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 56
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 65
KP_PREV Total estimated number of key population in the catchment area 2017 242
KP_PREV_den By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 142
KP_PREV_den By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 30
KP_PREV_den By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 70
OVC_SERV Age/Sex: 18+ Female 2017 502
OVC_SERV Age/Sex: 18+ Male 2017 415
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 1,433
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 1,340
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 3,690
OVC_SERV Sum of Age/Sex disaggregates 2017 917
PMTCT_ART Already on ART at beginning of current pregnancy 2017 36
PMTCT_ART New on ART 2017 28
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 715
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 43
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 10
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Sum of Infant Age disaggregates 2017 53
PMTCT_STAT By: Known positives at entry 2017 39
PMTCT_STAT By: Number of new positives identified 2017 27
PMTCT_STAT Number of new ANC and L&D clients 2017 732
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 715
PMTCT_STAT Sum of Positives Status disaggregates 2017 66
PP_PREV Aggregated Age/sex: <15 Female 2017 428
PP_PREV Aggregated Age/sex: <15 Male 2017 397
PP_PREV Aggregated Age/sex: 15+ Female 2017 504
PP_PREV Aggregated Age/sex: 15+ Male 2017 506
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 1,833
PP_PREV Total number of people in the target population 2017 17,821
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 23
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 33
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 33
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 620
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 61
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 187
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 372
TB_SCREENDX Screen Result: Screened Positive for TB 2017 155
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 4,868
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,507
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 196
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 172
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 7,743
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 25
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 41
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 71
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 71
TX_CURR Age/Sex: <1 2017 15
TX_CURR Age/Sex: <1-9 2017 88
TX_CURR Age/Sex: 10-14 Female 2017 143
TX_CURR Age/Sex: 10-14 Male 2017 122
TX_CURR Age/Sex: 15-19 Female 2017 244
TX_CURR Age/Sex: 15-19 Male 2017 75
TX_CURR Age/Sex: 20-24 Female 2017 1,119
TX_CURR Age/Sex: 20-24 Male 2017 502
TX_CURR Age/Sex: 25-49 Female 2017 3,261
TX_CURR Age/Sex: 25-49 Male 2017 1,805
TX_CURR Age/Sex: 50+ Female 2017 244
TX_CURR Age/Sex: 50+ Male 2017 125
TX_CURR Aggregated Age/Sex: <15 Female 2017 196
TX_CURR Aggregated Age/Sex: <15 Male 2017 172
TX_CURR Aggregated Age/Sex: 15+ Female 2017 4,868
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,507
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 7,743
TX_CURR Sum of age/sex disaggregates 2017 319
TX_CURR Sum of Aggregated Age/Sex <15 2017 368
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 7,375
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 7,743
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 78
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 68
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 606
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 312
TX_NEW By Age/Sex: <1 2017 6
TX_NEW By Age/Sex: 1-9 2017 36
TX_NEW By Age/Sex: 10-14 Female 2017 57
TX_NEW By Age/Sex: 10-14 Male 2017 47
TX_NEW By Age/Sex: 15-19 Female 2017 30
TX_NEW By Age/Sex: 15-19 Male 2017 10
TX_NEW By Age/Sex: 20-24 Female 2017 139
TX_NEW By Age/Sex: 20-24 Male 2017 62
TX_NEW By Age/Sex: 25-49 Female 2017 406
TX_NEW By Age/Sex: 25-49 Male 2017 225
TX_NEW By Age/Sex: 50+ Female 2017 31
TX_NEW By Age/Sex: 50+ Male 2017 15
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,064
TX_NEW Sum of Age/Sex disaggregates 2017 1,022
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,064